CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors

PURPOSE: Pancreatic cancer is associated with a high mortality rate owing to insufficient approaches for early diagnosis and the invasive biological behavior of the cancer. CD26 is a membrane-anchored protein involved in multiple physiological and pathological processes. Here, we investigated correl...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Onco Targets Ther
Main Authors: Yan, Liang, Tian, Xiuyun, Ye, Chunxiang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Wu, Jianhui, Hao, Chunyi
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737554/
https://ncbi.nlm.nih.gov/pubmed/33335402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S278736
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki